DexTech Medical AB (XSAT:DEX) COGS-to-Revenue : 0.00 (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is DexTech Medical AB COGS-to-Revenue?

DexTech Medical AB's Cost of Goods Sold for the three months ended in Mar. 2025 was kr-0.52 Mil. Its Revenue for the three months ended in Mar. 2025 was kr0.00 Mil.

DexTech Medical AB's COGS to Revenue for the three months ended in Mar. 2025 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. DexTech Medical AB's Gross Margin % for the three months ended in Mar. 2025 was %.

DexTech Medical AB COGS-to-Revenue Historical Data

The historical data trend for DexTech Medical AB's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexTech Medical AB COGS-to-Revenue Chart

DexTech Medical AB Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

COGS-to-Revenue

Get a 7-Day Free Trial

DexTech Medical AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

DexTech Medical AB COGS-to-Revenue Calculation

DexTech Medical AB's COGS to Revenue for the fiscal year that ended in Jun. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	-5.385	/	0
	=

DexTech Medical AB's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	-0.515	/	0
	=

DexTech Medical AB (XSAT:DEX) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

DexTech Medical AB's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	-0.515 / 0
	=	%

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

DexTech Medical AB COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of DexTech Medical AB's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

DexTech Medical AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DexTech Medical AB (XSAT:DEX) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Dag Hammarskjolds Vag 34A, Uppsala, SWE, 752 37

Website

https://www.dextechmedical.com

DexTech Medical AB develops candidate medications with applications within urological oncology, for prostate cancer. Its medication candidates include GuaDex, OsteoDex, and SomaDex, among others. The company conducts operations in medical research with the development of new drug candidates mainly in urological oncology, but also other cancer diseases and for non-malignant diseases. The company has a well built clinical base with valuable specialist expertise from research laboratories and manufacturing to clinical oncology.